Onchocerciasis

Onchocerciasis or river blindness is the world's second leading infectious cause of blindness. It is caused by Onchocerca volvulus, a Parasitic worm that can live for up to fifteen years in the human body. (From the Wikpedia article Onchocerciasis.)

Download PDF

Recent Publications on Onchocerciasis:
Major sperm protein as a diagnostic antigen for onchocerciasis. Onchocerciasis, also known as river blindness, is the second leading...	18th July, 2008	Departments of Chemistry and Immunology, The Skaggs Institute for Chemical	Bioorg Med Chem. 2008 Jun 25;. DOI Direct Link
After a decade of annual dose of mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Objective To evaluate the effectiveness of 10 years' annual single dose...	18th July, 2008	The Carter Center, Atlanta, GA, USA.	Trop Med Int Health. 2008 Jul 8;. DOI Direct Link
Free to fight disease. Onchocerciasis or river blindness, caused by the filarial nematode...	12th July, 2008		Nat Med. 2008 Jun;14(6):594-7. DOI Direct Link
Does resistance to filarial reinfections become leaky over time? Strategies for the control of human parasitic diseases such as...	24th June, 2008	Department of Medical Biometry, University of Tubingen, Westbahnhofstrasse	Trends Parasitol. 2008 Jun 19;. DOI Direct Link
UMF-078: A modified flubendazole with potent macrofilaricidal activity against Onchocerca ochengi in African cattle. ABSTRACT: BACKGROUND: Human onchocerciasis or river blindness, caused by...	24th June, 2008	Veterinary Parasitology, Liverpool School of Tropical Medicine/Faculty of	Parasit Vectors. 2008 Jun 20;1(1):18. DOI Direct Link
→View more research publications.

Onchocerciasis Clinical Trials:
Study Evaluating Orally Administered Moxidectin in Subjects With Onchocerca Volvulus Infection	Onchocerciasis Interventions: Drug: moxidectin;   Drug: ivermectin

Onchocerciasis Patents:
US Patent No.	Title
7202259	Therapeutic agents useful for treating pain
7250500	Nematode PAN and ZP receptor-like sequences
7256267	Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
7262194	Therapeutic agents useful for treating pain
7262859	Systems and methods for measurement optimization
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Onchocerciasis scientists - we have details of around 366 individuals working on Onchocerciasis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.